Feb 24 (Reuters) - Australian Clinical Labs Ltd (ACL) :
- HY STAT PROFIT ATTRIBUTABLE UP 200.7% TO A$130.2M
- HY STATUTORY TOTAL REVENUE FROM ORDINARY ACTIVITIES UP 69.2% A$538.0M
- DECLARES FY2022 INTERIM DIVIDEND 12.00 AU CPS
Feb 24 (Reuters) - Australian Clinical Labs Ltd (ACL) : HY STAT...
Add to My Watchlist
What is My Watchlist?